跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确研究中介路径特定因果效应、暴露诱导混杂与稳健估计,直接属于因果推断方向。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
C H Miles
I Shpitser
P Kanki
S Meloni

存在中介—结局混杂时路径特定效应的半参数估计

研究问题
当暴露诱导的变量会混杂中介与结局关系时,如何估计经过目标中介、但不经过该混杂变量的路径特定效应?
方法与思路
作者构造依赖观测数据似然不同部分的一组半参数估计量,比较其稳健性,其中一个兼具局部半参数效率与多重稳健性。
材料陈述的贡献
摘要称该估计量的多重稳健性支持使用机器学习估计干扰函数,并通过模拟及 HIV 药物治疗研究展示相关性质。
阅读关注点
应核对目标路径效应的识别条件、各估计量需要正确设定的似然部分,以及机器学习干扰估计满足推断要求的条件。
阅读边界
仅依据所给 Crossref 摘要;放宽既有混杂假设不等于消除所有混杂限制,摘要未列识别条件、效率界或机器学习适用条件。

原文摘要

Summary Path-specific effects constitute a broad class of mediated effects from an exposure to an outcome via one or more causal pathways along a set of intermediate variables. Most of the literature concerning estimation of mediated effects has focused on parametric models, with stringent assumptions regarding unmeasured confounding. We consider semiparametric inference of a path-specific effect when these assumptions are relaxed. In particular, we develop a suite of semiparametric estimators for the effect along a pathway through a mediator, but not through an exposure-induced confounder of that mediator. These estimators have different robustness properties, as each depends on different parts of the likelihood of the observed data. One estimator is locally semiparametric efficient and multiply robust. The latter property implies that machine learning can be used to estimate nuisance functions. We demonstrate these properties, as well as finite-sample properties of all the estimators, in a simulation study. We apply our method to an HIV study, in which we estimate the effect comparing two drug treatments on a patient’s average log CD4 count mediated by the patient’s level of adherence, but not by previous experience of toxicity, which is clearly affected by which treatment the patient is assigned to and may confound the effect of the patient’s level of adherence on their virologic outcome.

笔记与分组
相关领域论文